# IGF-1 and Bone Loss in Women With Anorexia Nervosa

> **NCT01406444** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 148 (actual)

## Conditions studied

- Anorexia Nervosa
- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** rhIGF-1
- **DRUG:** Risedronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01406444
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406444, "IGF-1 and Bone Loss in Women With Anorexia Nervosa". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01406444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*